查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1541407

2024-2032 年按适应症（气喘、慢性阻塞性肺病等）、药物类型、给药途径和地区分類的支气管扩张剂市场报告

Bronchodilators Market Report by Indication (Asthma, Chronic Obstructive Pulmonary Disease, and Others), Drug Type, Route of Administration, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 135 Pages | 商品交期: 2-3个工作天内

价格

IMARC Group年，全球支气管扩张剂市场规模达376亿美元。

支气管扩张剂是用于治疗长期患有气道狭窄和发炎疾病的患者的药物，例如气喘、肺气肿和慢性阻塞性肺病 (COPD)。它们透过放鬆气道或支气管周围的肌肉、清除肺部黏液并使呼吸更容易来帮助缓解相关症状。它们有片剂、液体、雾化溶液、定量吸入器和干粉吸入器的形式。如今，支气管扩张剂也被用来增强吸入性皮质类固醇的效果，吸入性皮质类固醇是减少发炎和预防气喘发作的主要治疗方法。

支气管扩张剂市场趋势：

冠状病毒病（COVID-19）引起的急性呼吸道感染患者数量显着增加，是影响全球支气管扩张剂需求的关键因素之一。除此之外，世界各地日益严重的空气污染、吸烟者数量的增加以及传染病的日益流行都增加了肺部疾病的风险。这是市场的另一个成长诱导因素。此外，随着年龄的增长，肺功能逐渐下降，这会使呼吸略有困难。再加上老年人口的增加和消费者支出能力的大幅提高，正在推动市场发展。其他因素，例如改善医疗基础设施和诊断方式以及日益转向非侵入性手术，也正在推动市场成长。此外，几种可以帮助克服现有产品限制的新型支气管扩张剂正处于临床前阶段。同时，许多国家的卫生机构正在支持支气管扩张剂的研发（R&D）活动，预计将为市场创造积极的前景。

本报告回答的关键问题

  • 全球支气管扩张剂市场有多大？ 2024-2032年全球支气管扩张剂市场的预期成长率是多少？
  • 推动全球支气管扩张剂市场的关键因素是什么？
  • COVID-19 对全球支气管扩张剂市场有何影响？
  • 根据该指标，全球支气管扩张剂市场的细分如何？
  • 根据药物类型，全球支气管扩张剂市场的细分如何？
  • 根据给药途径，全球支气管扩张剂市场的细分如何？
  • 全球支气管扩张剂市场的关键区域有哪些？
  • 全球支气管扩张剂市场的主要参与者/公司有哪些？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 数据来源
    • 主要来源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球支气管扩张剂市场

  • 市场概况
  • 市场表现
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：依迹象

  • 气喘
    • 市场趋势
    • 市场预测
  • 慢性阻塞性肺病（COPD）
    • 市场趋势
    • 市场预测
  • 其他的
    • 市场趋势
    • 市场预测

第 7 章：市场区隔：按药物类型

  • 拟交感神经药
    • 市场趋势
    • 市场预测
  • 抗胆碱药
    • 市场趋势
    • 市场预测
  • 磷酸二酯酶抑制剂
    • 市场趋势
    • 市场预测
  • 复方药物
    • 市场趋势
    • 市场预测

第 8 章：市场区隔：依管理途径

  • 口服
    • 市场趋势
    • 市场预测
  • 注射
    • 市场趋势
    • 市场预测
  • 吸入器
    • 市场趋势
    • 市场预测

第 9 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场趋势
    • 市场细分：按国家/地区
    • 市场预测

第 10 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 11 章：价值链分析

第 12 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 13 章：价格分析

第14章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Abbott Laboratories
    • AstraZeneca plc
    • Boehringer Ingelheim International GmbH
    • F. Hoffmann-La Roche Ltd
    • GlaxoSmithKline plc
    • Novartis AG
    • Pfizer Inc.
    • Sanofi
    • Teva Pharmaceutical Industries Ltd.
    • Vectura Group plc
Product Code: SR112024A4184

The global bronchodilators market size reached US$ 37.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 55.9 Billion by 2032, exhibiting a growth rate (CAGR) of 4.4% during 2024-2032.

Bronchodilators are medications used to treat patients suffering from long-term conditions of narrow and inflamed airways, such as asthma, emphysema, and chronic obstructive pulmonary disease (COPD). They help relieve associated symptoms by relaxing the muscles around the airways or bronchi, clearing mucus from the lungs, and making breathing easier. They are available in the form of tablets, liquid, nebulizer solutions, and metered-dose and dry powder inhalers. Nowadays, bronchodilators are also utilized to enhance the effect of inhaled corticosteroids, which act as a primary treatment to reduce inflammation and prevent flare-ups in asthma.

Bronchodilators Market Trends:

A significantly rising number of patients with acute respiratory infections due to coronavirus disease (COVID-19) represents one of the key factors influencing the need for bronchodilators across the globe. Apart from this, increasing levels of air pollution, the rising number of smokers, and the growing prevalence of infectious diseases around the world are contributing to the risk of developing lung conditions. This is acting as another growth-inducing factor of the market. In addition, lung function declines gradually with age, which can make breathing slightly difficult. This, along with the increasing geriatric population and a considerable rise in consumer spending capacities, is driving the market. Other factors, such as improving healthcare infrastructure and diagnostic modalities and rising shift towards non-invasive procedures, are also propelling the market growth. Furthermore, several new classes of bronchodilators that can help overcome the limitations of existing products are in the preclinical phase stage. In confluence with this, health agencies of numerous countries are supporting research and development (R&D) activities for bronchodilators, which is anticipated to create a positive outlook for the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global bronchodilators market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on indication, drug type and route of administration.

Breakup by Indication:

Asthma

Chronic Obstructive Pulmonary Disease (COPD)

Others

Breakup by Drug Type:

Sympathomimetics

Anticholinergics

Phosphodiesterase Inhibitor

Combination Drugs

Breakup by Route of Administration:

Oral

Injection

Inhaler

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, AstraZeneca plc, Boehringer Ingelheim International GmbH, F. Hoffmann-La Roche Ltd, GlaxoSmithKline plc, Novartis AG, Pfizer Inc., Sanofi, Teva Pharmaceutical Industries Ltd. and Vectura Group plc.

Key Questions Answered in This Report

  • 1. How big is the global bronchodilators market?
  • 2. What is the expected growth rate of the global bronchodilators market during 2024-2032?
  • 3. What are the key factors driving the global bronchodilators market?
  • 4. What has been the impact of COVID-19 on the global bronchodilators market?
  • 5. What is the breakup of the global bronchodilators market based on the indication?
  • 6. What is the breakup of the global bronchodilators market based on the drug type?
  • 7. What is the breakup of the global bronchodilators market based on the route of administration?
  • 8. What are the key regions in the global bronchodilators market?
  • 9. Who are the key players/companies in the global bronchodilators market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Bronchodilators Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Indication

  • 6.1 Asthma
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Chronic Obstructive Pulmonary Disease (COPD)
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Others
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Drug Type

  • 7.1 Sympathomimetics
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Anticholinergics
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Phosphodiesterase Inhibitor
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Combination Drugs
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Route of Administration

  • 8.1 Oral
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Injection
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Inhaler
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 AstraZeneca plc
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Boehringer Ingelheim International GmbH
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 F. Hoffmann-La Roche Ltd
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 SWOT Analysis
    • 14.3.5 GlaxoSmithKline plc
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Novartis AG
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Pfizer Inc.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Sanofi
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Teva Pharmaceutical Industries Ltd.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Vectura Group plc
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Bronchodilators Market: Major Drivers and Challenges
  • Figure 2: Global: Bronchodilators Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Bronchodilators Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Bronchodilators Market: Breakup by Indication (in %), 2023
  • Figure 5: Global: Bronchodilators Market: Breakup by Drug Type (in %), 2023
  • Figure 6: Global: Bronchodilators Market: Breakup by Route of Administration (in %), 2023
  • Figure 7: Global: Bronchodilators Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Bronchodilators (Asthma) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Bronchodilators (Asthma) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Bronchodilators (Chronic Obstructive Pulmonary Disease - COPD) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Bronchodilators (Chronic Obstructive Pulmonary Disease - COPD) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Bronchodilators (Other Indications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Bronchodilators (Other Indications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Bronchodilators (Sympathomimetics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Bronchodilators (Sympathomimetics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Bronchodilators (Anticholinergics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Bronchodilators (Anticholinergics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Bronchodilators (Phosphodiesterase Inhibitor) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Bronchodilators (Phosphodiesterase Inhibitor) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Bronchodilators (Combination Drugs) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Bronchodilators (Combination Drugs) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Bronchodilators (Oral) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Bronchodilators (Oral) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Bronchodilators (Injection) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Bronchodilators (Injection) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Bronchodilators (Inhaler) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Bronchodilators (Inhaler) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: North America: Bronchodilators Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: North America: Bronchodilators Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: United States: Bronchodilators Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: United States: Bronchodilators Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Canada: Bronchodilators Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Canada: Bronchodilators Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Asia-Pacific: Bronchodilators Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Asia-Pacific: Bronchodilators Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: China: Bronchodilators Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: China: Bronchodilators Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Japan: Bronchodilators Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Japan: Bronchodilators Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: India: Bronchodilators Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: India: Bronchodilators Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: South Korea: Bronchodilators Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: South Korea: Bronchodilators Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Australia: Bronchodilators Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Australia: Bronchodilators Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Indonesia: Bronchodilators Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Indonesia: Bronchodilators Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Others: Bronchodilators Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Others: Bronchodilators Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Europe: Bronchodilators Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Europe: Bronchodilators Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Germany: Bronchodilators Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Germany: Bronchodilators Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: France: Bronchodilators Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: France: Bronchodilators Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: United Kingdom: Bronchodilators Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: United Kingdom: Bronchodilators Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Italy: Bronchodilators Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Italy: Bronchodilators Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Spain: Bronchodilators Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Spain: Bronchodilators Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Russia: Bronchodilators Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Russia: Bronchodilators Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Others: Bronchodilators Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Others: Bronchodilators Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Latin America: Bronchodilators Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Latin America: Bronchodilators Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Brazil: Bronchodilators Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Brazil: Bronchodilators Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Mexico: Bronchodilators Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Mexico: Bronchodilators Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Others: Bronchodilators Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Others: Bronchodilators Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Middle East and Africa: Bronchodilators Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Middle East and Africa: Bronchodilators Market: Breakup by Country (in %), 2023
  • Figure 76: Middle East and Africa: Bronchodilators Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Global: Bronchodilators Industry: SWOT Analysis
  • Figure 78: Global: Bronchodilators Industry: Value Chain Analysis
  • Figure 79: Global: Bronchodilators Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Bronchodilators Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Bronchodilators Market Forecast: Breakup by Indication (in Million US$), 2024-2032
  • Table 3: Global: Bronchodilators Market Forecast: Breakup by Drug Type (in Million US$), 2024-2032
  • Table 4: Global: Bronchodilators Market Forecast: Breakup by Route of Administration (in Million US$), 2024-2032
  • Table 5: Global: Bronchodilators Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Bronchodilators Market: Competitive Structure
  • Table 7: Global: Bronchodilators Market: Key Players